GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
123.11
+6.70 (5.76%)
At close: Aug 13, 2025, 4:00 PM
119.22
-3.89 (-3.16%)
Pre-market: Aug 14, 2025, 9:06 AM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $3.54 billion as of August 14, 2025. Its market cap has increased by 301.41% in one year.
Market Cap
3.54B
Enterprise Value
3.52B
1-Year Change
301.41%
Ranking
Category
Stock Price
$123.11
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.54B, a decrease of -80.24%. That is a compound annual growth rate of -28.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3.54B | 67.49% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |